2026 NPPES data General Practice Physician NPI 1053413765 M.D.
Verify on CMS →

SINA RAFISOLYMAN, M.D.

General Practice Physician in FRESNO, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
61
Medicare Part D claims · General Practice Physician avg: 3K
Generic prescribing
57%
generic claims · 43% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

SINA RAFISOLYMAN, M.D. filed 61 Medicare Part D claims in 2023 as a General Practice Physician in FRESNO, California, prescribing 57% generic.

61
Part D claims, 2023
57%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

SINA RAFISOLYMAN, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

61 0th percentile higher than 0% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). This entry sits in this band. 200–400: 182,923 prescribers (13%). Above this entry. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic — not verified)

SINA RAFISOLYMAN, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about SINA RAFISOLYMAN, M.D.?

Quality data not reported

NPI registry status

Active

Issued 09/02/2006

NPI 1053413765

Primary specialty

General Practice Physician

Mid-sized

16,677 US NPIs in this specialty

Medicare Part D claims

61 98% vs specialty avg

2023 prescription claims

Specialty avg: 2,872

Specialty distribution in California

How General Practice Physician compares to other specialties among California providers

California providers

General Practice Physician share within California

1. General Practice Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
General Practice Physician share within California

Specialty board-certification context

Estimated specialty board-certified rate — General Practice Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
General Practice Physician ABMS/AOA estimate

Est. board-certified rate (General Practice Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (General Practice Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

SINA RAFISOLYMAN, M.D. appears in the CMS NPPES registry as a General Practice Physician provider holding M.D. credentials at 2841 TULARE STREET, FRESNO, CA, 93721, with a listed phone of (559) 435-3696. NPI 1053413765 was issued on 09/02/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what RAFISOLYMAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 61 prescription claims written by this provider, covering N/A Medicare beneficiaries and totaling roughly $16K in drug spend, split 43% brand-name and 57% generic by claim count, with an opioid prescribing rate of 19.7%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

General Practice Physician is a mid-sized specialty nationwide, with 16,677 enrolled providers across 56 states and an average of 2,872 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

2841 TULARE STREET
FRESNO, CA 93721

Provider Details

NPI 1053413765
Specialty General Practice Physician
Credentials M.D.
Gender Male
NPI Issued 09/02/2006

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to SINA RAFISOLYMAN, M.D.. To verify SINA RAFISOLYMAN, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

SINA RAFISOLYMAN, M.D. — brand share 43.0%
Specialty average (est.)

43% brand-name claims vs 57% generic, on 61 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

61
Total Claims
$16K
Total Drug Cost
N/A
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
81
Total Day Supply
2,106
Brand vs Generic
43% brand / 57% generic
Brand Drug Cost
$14K
Generic Drug Cost
$1K
Opioid Claims
12 (19.7% rate)

Patient Demographics

Average Patient Age
74.5 years
Avg HCC Risk Score
1.70

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Alprazolam
12
Hydrocodone-Acetaminophen
Hydrocodone/Acetaminophen
12

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

General Practice Physician Overview

How SINA RAFISOLYMAN, M.D. fits within the General Practice Physician landscape nationally.

16,677
General Practice Physician Providers in US
56
States with General Practice Physician
2,872
Avg Claims per Provider

SINA RAFISOLYMAN, M.D.'s 61 claims are below the specialty average of 2,872.

Nearby General Practice Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as RAFISOLYMAN.

Compare General Practice Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is SINA RAFISOLYMAN, M.D.'s specialty?
SINA RAFISOLYMAN, M.D. specializes in General Practice Physician and practices in FRESNO, California. Credentials: M.D..
How much does SINA RAFISOLYMAN, M.D. prescribe under Medicare Part D?
In 2023, SINA RAFISOLYMAN, M.D. wrote 61 Medicare Part D claims totaling $16K in drug costs for N/A beneficiaries.
Where is SINA RAFISOLYMAN, M.D. located?
SINA RAFISOLYMAN, M.D. is located at 2841 TULARE STREET, FRESNO, CA, 93721. Phone: (559) 435-3696.
What is SINA RAFISOLYMAN, M.D.'s NPI number?
SINA RAFISOLYMAN, M.D.'s National Provider Identifier (NPI) is 1053413765, issued on 09/02/2006.
Does SINA RAFISOLYMAN, M.D. prescribe more brand-name or generic drugs?
SINA RAFISOLYMAN, M.D.'s prescribing is 43% brand-name and 57% generic drugs by claim count, with $14K in brand drug costs.
Does SINA RAFISOLYMAN, M.D. prescribe opioids?
Yes, SINA RAFISOLYMAN, M.D. had 12 opioid claims in 2023 with an opioid prescribing rate of 19.7%.
How many General Practice Physician providers are there in the US?
There are 16,677 General Practice Physician providers across 56 states in the US. The average General Practice Physician provider writes 2,872 Medicare Part D claims per year.
What drugs does SINA RAFISOLYMAN, M.D. prescribe most often?
Based on 2023 Medicare Part D data, SINA RAFISOLYMAN, M.D.'s most frequently prescribed drugs include Alprazolam, Hydrocodone-Acetaminophen. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does SINA RAFISOLYMAN, M.D. accept Medicare?
SINA RAFISOLYMAN, M.D. appears in CMS Medicare data with 61 Part D claims and N/A Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify SINA RAFISOLYMAN, M.D.'s credentials?
SINA RAFISOLYMAN, M.D.'s NPI is 1053413765 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology